Fluorogenic Substrate Labeled Separation-Free Enzyme Mediated Immunoassays for Haptens and Macromolecules

  • That T. Ngo
  • Raphael C. Wong


Fluorogenic substrate labeled separation-free enzyme mediated immunoassay, hereafter abbreviated as FSIA (Boguslaski et al., 1980; Burd, 1981) (it is also known as Substrate-labeled Fluorescent Immunoassay) uses a modified fluorogenic enzyme substrate as a label to form a stable covalent substrate-analyte ligand conjugate. This is in contrast to most enzyme mediated immunoassays which use an enzyme rather than an enzyme substrate as the label (Ngo and Lenhoff, 1981 and 1982). There are two critical prerequisites that must be satisfied before a fluorogenic substrate can be used as a label in FSIA development: (1) the modified fluorogenic substrate after covalent conjugation to the analyte ligand must retain its function as an enzyme substrate and (2) the substrate-analyte ligand conjugate upon binding to an antibody specific to the ligand must not be able to serve as an enzyme substrate. By definition, a fluorogenic enzyme substrate should not fluoresce at the wavelength used to monitor the assay; however, its enzymatic product should exhibit strong fluorescence at the appropriate monitoring wavelengths. The substrate-analyte ligand conjugate in FSIA serves as a modified enzyme substrate capable of binding to the active-site of an enzyme and being transformed into a detectable product.


Flavin Adenine Dinucleotide Enzyme Substrate Flavin Adenine Dinucleotide Fluorogenic Substrate Fluorescent Immunoassay 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Benovic, J.L., Cary, L.C., Li, T.M., Hatch, R.P., and Burd, J.F., 1982, Substrate-labeled fluorescent immunoassay for caffeine in human serum, Clin Chem, 28, 1666.Google Scholar
  2. Boguslaski, R.C., Li, T.M., Benovic, J.L., Ngo, T.T., Burd, J.F. and Carrico, R.C., 1980, Substrate labeled homogeneous fluorescent immunoassays for haptens and proteins, in: “Immunoassays: Clinical Laboratory Techniques for the 1980’s,” R.M. Nakamura, W.R. Dito, E.S. Tucker III, ed., Alan Liss, New York, pp. 45–64.Google Scholar
  3. Burd, J.F., Wong, R.C., Feeney, J.E., Carrico, R.J. and Boguslaski, R.C., 1977, Homogeneous reactant labeled fluorescent immunoassay for therapeutic drugs exemplified by gentamicin determination in human serum, Clin Chem, 23, 1402–1408.PubMedGoogle Scholar
  4. Burd, J.F., Carrico, R.J., Kramer, H.M. and Denning, C.E., 1978, Homogeneous substrate-labeled fluorescent immunoassay for determining tobramycin concentrations in human serum, in: “Enzyme Labelled Immunoassay of Hormones and Drugs,” S.B. Pal, ed., Walter de Gruyter and Company, Berlin-New York, pp. 387–403.Google Scholar
  5. Burd, J.F., 1981, The homogeneous substrate-labeled fluorescent immunoassay, in: “Methods in Enzymology,” Volume 74, J.J. Langone and H.V. Vunakis, ed., Academic Press, New York, PP. 79–87.Google Scholar
  6. Cope, A.C., Hofmann, C.M., Wyckoff, C. and Hardenbergh, E., 1941, Condensation reactions. II. alkyldene cyanoacetic and malonic esters, J Am Chem Soc, 63, 3452.CrossRefGoogle Scholar
  7. Csiszar, L., Li, T.M., Benovic, J.L., Buckler, R.T. and Burd, J.F., 1981, Substrate-labeled fluorescent immunoassay for quinidine, Clin Chem, 27, 1087.Google Scholar
  8. deCastro, A.F., Lam, C.T., Place, J., Parker, D. and Patel, C., 1984, Kanamycin concentration in serum using a substrate-labeled fluorescent immunoassay, Clin Chem, 30, 1027.Google Scholar
  9. Feinstein, H., Hovav, H., Fridlender, B., Inbar, D. and Buckler, R. T., 1982, Substrate-labeled fluorescent immunoassay (SLFIA) for valproic acid, Clin Chem, 28, 1665.Google Scholar
  10. Greenquist, A.C., Walter, B. and Li, T.M., 1981, Homogeneous fluorescent immunoassay with dry reagents, Clin Chem, 27, 1614–1617.PubMedGoogle Scholar
  11. Johnson, P.K., Messenger, L.J., Krausz, L.M., Buckler, R.T. and Burd, J.F., 1981, Substrate-labeled fluorescent immunoassay for primidone, Clin Chem, 27, 1093.Google Scholar
  12. Krausz, L.M., Hitz, J.B., Buckler, R.T. and Burd, J.F., 1980, Substrate-labeled fluorescent immunoassay for phenobarbital, Ther Drug Monit, 2, 261–272.PubMedCrossRefGoogle Scholar
  13. Leaback, D.H., 1965, Preparation of methylumbelliferyl-β-D-galacto-side, Clin Chim Acta, 12, 658.Google Scholar
  14. Li, T.M., Benovic, J.L., Buckler, R.T. and Burd, J.F., 1981, Homogeneous substrate-labeled fluorescent immunoassay for theophylline in serum, Clin Chem, 27, 22–26.PubMedGoogle Scholar
  15. Li, T.M. and Burd, J.F., 1981, Enzymic hydrolysis of intramolecular complexes for monitoring theophylline in homogeneous competitive protein-binding reactions, Biochem Biophys Res Comm, 31, 1157–1165.CrossRefGoogle Scholar
  16. Li, T.M., Miller, J.E., Ward, F.E. and Burd, J.F., 1982, Homogeneous substrate-labeled fluorescent immunoassay for carbamazepine, Epilepsia, 23, 391–398.PubMedCrossRefGoogle Scholar
  17. Lima, J.J., Shields, B.J., Howell, L.H. and Mackichan, J.J., 1984, Evaluation of fluorescence immunoassay for total and unbound serum concentrations of disopyramide, Ther Drug Monit, 6, 203–210.PubMedCrossRefGoogle Scholar
  18. Ngo, T.T., Carrico, R.J., Boguslaski, R.C. and Burd, J.F., 1981, Homogeneous substrate-labeled fluorescent immunoassay for IgG in human serum, J. Immunolog Methods, 42, 93–104.CrossRefGoogle Scholar
  19. Ngo, T.T. and Lenhoff, H.M., 1981, Recent advances in homogeneous and separation-free enzyme immunoassays, Applied Biochem Biotechnol, 6, 53–64.CrossRefGoogle Scholar
  20. Ngo, T.T. and Lenhoff, H.M., 1982, Enzymes as versatile labels and signal amplifiers for monitoring immunochemical reactions, Mol Cell Biochem, 44, 3–12.PubMedCrossRefGoogle Scholar
  21. Pahuski, E.E., Hixson, C.S., Petrozolin, A.K., Hatch, R.P. and Li, T.M., 1982, Homogeneous substrate-labeled fluorescent immunoassay (SLFIA) for ethosuximide in human serum, Clin Chem, 28, 1664.Google Scholar
  22. Pahuski, E.E., Manzuk, D.M., Maurer, J.L. and Li, T.M., 1983, Total automation of the SLFIA’s for ethosuximide and valproic acid, Clin Chem, 29, 1236.Google Scholar
  23. Place, J.D. and Thompson, S.G., 1983, Substrate-labeled fluorescent immunoassay for measuring dibekacin concentrations in serum and plasma, Antimicrob Agents Chemother, 24, 240–245.PubMedGoogle Scholar
  24. Terumo Corp., 1983, Sept. 7, Japan Patent No. 58,150,861, Immunoassay for the determination of drugs.Google Scholar
  25. Thompson, S.G. and Burd, J.F., 1980, Substrate-labeled fluorescent immunoassay for amikacin in human serum, Antimicrob Agents Chemother, 18, 264–268.PubMedGoogle Scholar
  26. Walter, B., Greenquist, A.C. and Howard, III W.E., 1983, Solid-phase strips for detection of therapeutic drugs in serum by substrate-labeled fluorescent immunoassay, Anal Chem, 55, 873–878.PubMedCrossRefGoogle Scholar
  27. Weetall, H.H. and Odstrchel, G., 1976, A biased solid-phase radioimmunoassay for thyroxine (T4) using T4– 125I presaturated antibodies, J Solid-phase Biochem, 1, 241–245.Google Scholar
  28. Wong, R.C., Burd, J.F., Carrico, R.J., Buckler, R.T., Thoma, J. and Boguslaski, R.C., 1979, Substrate-labeled fluorescent immunoassay for phenytoin in human serum, Clin Chem, 25, 686–691.PubMedGoogle Scholar
  29. Wong, R.C., George, R., Yeung, R. and Burd, J.F., 1980, A comparison of serum phenytoin determination by the substrate-labeled fluorescent immunoassay with gas chromatography, liquid chromatography, radioimmunoassay and ‘EMIT’, Clin Chim Acta, 100, 65–69.PubMedCrossRefGoogle Scholar
  30. Worah, D., Yeung, K.K., Ward, F.E. and Carrico, R.J., 1981, A homogeneous fluorescent immunoassay for human immunoglobulin M., Clin Chem, 27, 673–677.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • That T. Ngo
    • 1
  • Raphael C. Wong
    • 1
  1. 1.Department of Developmental and Cell BiologyUniversity of CaliforniaIrvineUSA

Personalised recommendations